Nanoemulsion as potential vehicles for transdermal delivery of pure phytopharmaceuticals and poorly soluble drug

International Journal of Drug Delivery

Volumn 1, Issue 2, 2011, Pages 209-218

  Harwansh, Ranjit Kumar ^a   Patra, Kartik Ch ^a   Pareta, Surendra K ^a  

^a GURU GHASIDAS UNIVERSITY   (India)

Author keywords

Nanoemulsion; Phytopharmaceuticals; Poorly soluble drug; Transdernmal

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ACECLOFENAC; ALCOHOL; CLONIDINE; CREMOPHOR; CURCUMIN; DECYL METHYL SULFOXIDE; DIETHYLENE GLYCOL MONOETHYL ETHER; DIMETHYL SULFOXIDE; DODECYLBENZENESULFONATE SODIUM; FATTY ACID; GLYCERYL TRINITRATE; HESPERETIN; LAUROCAPRAM; MACROGOL 400; MYRISTIC ACID ISOPROPYL ESTER; NICOTINE; OLEIC ACID; OLIVE OIL; PLANT MEDICINAL PRODUCT; POLYSORBATE 80; PROPYLENE GLYCOL; SCOPOLAMINE; SORBITAN OLEATE; SURFACTANT; TERPENE; TRIPTOLIDE; UNINDEXED DRUG; UREA; WATER OIL CREAM; FENTANYL; KERATIN; PENETRATION ENHANCING AGENT;

CONCENTRATION (PARAMETERS); DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; ELECTROPORATION; FIRST PASS EFFECT; HUMAN; HYDRATION; HYDROPHILICITY; HYDROPHOBICITY; IONTOPHORESIS; MICELLE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PATIENT COMPLIANCE; REVIEW; STRATUM CORNEUM; SYSTEMIC CIRCULATION; TRANSDERMAL DRUG ADMINISTRATION; CARDIOVASCULAR DISEASE; CHRONIC PAIN; DRUG DOSAGE FORM COMPARISON; DRUG MIXTURE; FLUIDIZATION; MICROEMULSION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR WEIGHT; MOTION SICKNESS; NANOPHARMACEUTICS; PHASE PARTITIONING; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; SKIN IRRITATION; SKIN PENETRATION; SKIN PROTECTION; SKIN TOXICITY; THERMODYNAMICS; VALIDATION PROCESS;

EID: 84855190564     PISSN: None     EISSN: 09750215     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Shinoda K, Kunieda H. Phase properties of emulsions: PIT and HLB. In: Schuster D, ed. Encyclopedia of Emulsion Technology New York, NY: Marcel Dekker. 1983:337Y367.
2. Shafiq S, Faiyaz S, Sushma T, Ahmad FJ, Khar RK, Ali M. Design and development of oral oil in water ramipril nanoemulsion formulation: in vitro and in vivo evaluation. J Biomed Nanotech. 2007;3:28Y44.
3. Shafiq S, Faiyaz S, Sushma T, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227Y243.
4. Vladimir P, Tordilin. Nanoparticulates as Drug Carriers: Notheastern University. Imperial Collage Press 2006.
5. Amselem S, and Friedman D, Submicron emulsion in drug targeting and delivery.
6. Benita S. (eds) Harwood Academic: Amsterdam 1998.
7. Benita S, and Levy MY. Submicron emulsions as colloidal drug carrier for intravenous administration-comprehensive physicochemical characterization. J. Pharm. Sci. 1993;82:1069-1079
8. Bhargava HN, Narurkar A and Lieb LM, Using microemulsions for drug delivery. Pharmaceut Technol. 1987;11:46-54.
9. Osborne DW, Ward AJ, Neil KJ. Microemulsions as topical delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol. 1991;43:450Y454.
10. Faiyaz Shakeel, Sanjula Baboota, Alka Ahuja, Javed Ali, Mohammed Aqil And Sheikh Shafiq1. Nanoemulsions as Vehicles for Transdermal Delivery of Aceclofenac. AAPS Pharm Sci Tech. 2007;8(4):104.
11. Kawakami K, Yoshikawa T, Moroto Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs, I: prescription design. J Control Rel. 2002;81:65Y74.
12. Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin ATM. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm. 2005;288:27Y34.
13. Craig DQM, Barker SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 1995;114:103Y110.
14. Lee PJ, Langer R, Shastri VP. Novel microemulsion enhancer formulation for Simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res. 2003; 20: 264Y269.
15. Warisnoicharoen W, Lansley AB, Lawrence MJ. Light scattering investigations on dilute non-ionic oil-in-water microemulsions. AAPS Pharm Sci Tech [serial online]. 2002;2:E12.
16. Kreilgaard M, Kemme MJB, Burggraaf J, Schoemaker RC, Cohen AF. Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics. Pharm Res. 2001;18:593Y599.
17. Attwood D, Currie LRJ and Elworthy PH. Studies of Solubilized miceller solutions. 1. Phase studies and particle-size analysis of solution formed with non ionic surfactants. J Coll Interf Sci. 1974;46:249-254.
18. Gasco MR, Gallarate M, Pattarino F. In vitro permeation of azelaic acid from viscosized microemulsions. Int J Pharm. 1991;69:193Y196.
19. Benson HAE, Transdermal Drug Delivery: Penetration Enhancement Techniques. Current Drug Delivery. 2005;2:23-33.
20. Kriwet K, Muller-Goymann CC. Diclofenac release fromphospholipid drug systems and permeation through excised human stratum corneum. Int J Pharm. 1995;125:231Y242.
21. Flynn GL. In Percutaneous absorption, Bronaugh, R. L Maibach, HI, Eds. Marcel Dekker Inc. New York. 1985:17-52.
22. Kasting GB, Smith RL, Anderson BD. In Prodrugs: topical and ocular drug delivery, Sloan, K., Ed. Marcel Dekker Inc.: New York. 1992:117-161.
23. Potts RO, Guy RH. Pharm. Res. 1992;9:663-9.
24. Scheuplein RJ, Blank IH, Brauner GJ, MacFarlane DJ J. Invest Dermatol. 969; 52: 63-70.
25. Scheuplein RJ, Blank IH. Physiol. Rev. 1971;51:702-747.
26. Elias PM, McNutt NS, Friend DS. Anat. Rec. 1977;189:577-94.
27. Elias PM, Friend DS J, Cell Biol. 1975;65:180-191.
28. Nemanic MK, Elias PM, J. Histochem. Cytochem. 1980;28:573-8.
29. Potts R. O, Francoeur ML J. Invest Dermatol. 1991;96:495-9.
30. Bodde HE, Van den Brink I, Koerten H, De Haan FH. J. Control Rel. 1991;15:227-236.
31. Katz M, Poulsen BJ, Brodie BB, Gilette J. In Handbook of Experimental Pharmacology. Eds. Springer Verlag Berlin. 1971:103-174.
32. Yano T, Nakagawa A, Tsuji M, Noda K. Life Sci., 1986;39:1043-50.
33. Bos JD, Meinardi MM, Exp. Dermatol., 2000;9:165-9.
34. Barry BW, Eur. J. Pharm. Sci., 2001;14:101-14.
35. Asbill CS, El-Kattan AF, Michniak B. Crit. Rev. Ther. Drug Carrier Syst., 2000;17:621-58.
36. Hadgraft J. Int. J. Pharm., 1999:184:1-6.
37. Walters KA, Hadgraft J. Pharmaceutical Skin Penetration Enhancement. Drugs and the Pharmaceutical Sciences., New York: Marcel Dekker Inc. 1993: Vol. 59:440.
38. Barry BW. Int. J. Cosmet. Sci., 1988;10:281-293.
39. Barry BW. J. Control Rel., 1991;15:237-248.
40. Williams AC, Barry BW. Pharm. Res., 1991;8:17-24.
41. Behl CR, Flynn GL, Kurihara T, Harper N, Smith W, Higuchi WI, Ho NF, Pierson CL. J. Invest. Dermatol., 1980;75:346-52.
42. McKenzie AW, Stoughton RB. Arch. Dermatol., 1962;86:608-610.
43. Francoeur ML, Golden GM, Potts RO. Pharm. Res., 1990;7:621-7.
44. Yamane MA, Williams AC, Barry BW. J. Pharm. Pharmacol., 1995;47:978-89.
45. Walters K. A, Walker M, Olejnik O J. Pharm. Pharmacol. 1988;40:525-9.
46. Walters KA, Hadgraft J, Guy RH. In Transdermal drug delivery. Eds. Marcel Dekker: New York. 1988:197-246.
47. Wotton PK, Mollgaard B, Hadgraft J, Hoelgaard A. Int. J. Pharm., 1985;24:19-26.
48. Harrison JE, Watkinson AC, Green DM, Hadgraft J, Brain K. Pharm. Res., 1996;13:542-6.
49. Waranis RP, Siver KG, Sloan KB. Int. J. Pharm., 1987;36:211.
50. Yamane MA, Williams AC, Barry BW. J. Pharm. Pharmacol., 1995;47:978-89.
51. Pellett M A, Roberts MS, Hadgraft J. Int. J. Pharm., 1997;151:91-98.
52. Sloan KB. Sloan KB, Topical and Ocular Drug Delivery Ed. In Prodrugs, Marcel Dekker: New York. 1992:179-220.
53. Riviere JE, Heit MC. Pharm. Res., 1997;14:687-97.
54. Banga AK, Bose S, Ghosh TK. Int. J. Pharm., 1999;179:1-19.
55. Jadoul A, Bouwstra J, Preat VV. Adv. Drug Deliv. Rev., 1999;35:89-105.
56. Teichmann A, Heuschkel S, Jacobi U, Presse G, Eubert R HH, Sterry W, Lademann J. Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. European Journal of Pharmaceutics and Biopharmaceutics. 2007;67:699-706.
57. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. International Journal of Pharmaceutics. 2009;371:148-155.
58. Tsai Y, Lee K, Huang Y, Huang C, Wu P. In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system. International Journal of Pharmaceutics. 2010;388:257-262.
59. Lin C, Lin H, Chen H, Yu M, Lee M. Stability and characterisation of phospholipid-based curcumin-encapsulated Microemulsions. Food Chemistry. 2009;116:923-928.
60. Wu H, Ramachandran C, Weiner N D, Roessler B J. Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. International Journal of Pharmaceutics. 2001;220:63-75.
61. Xu J et al. The preparation of neem oil microemulsion (Azadirachta indica) and the comparison of acaricidal time between neem oil microemulsion and other formulations in vitro. Veterinary Parasitology. 2010;169:399-403.
62. Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. European Journal of Pharmaceutics and Biopharmaceutics. 2003;56:189-196.